{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:32:29Z","timestamp":1791639149783,"version":"4.3.4"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T00:00:00Z","timestamp":1563148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA016672"],"award-info":[{"award-number":["P30CA016672"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s00432-019-02945-9","type":"journal-article","created":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T05:06:01Z","timestamp":1563167161000},"page":"1977-1986","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Genetic profiling as a clinical tool in advanced parathyroid carcinoma"],"prefix":"10.1007","volume":"145","author":[{"given":"Merve","family":"Kutahyalioglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ha T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lily","family":"Kwatampora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callisia","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiman","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G.","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E.","family":"Cabanillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi I.","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven I.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Kopetz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Broaddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Dadu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kacey","family":"Wanland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Zafereo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3808-6378","authenticated-orcid":false,"given":"Naifa L.","family":"Busaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,15]]},"reference":[{"issue":"2","key":"2945_CR1","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/BF03347413","volume":"30","author":"A Agha","year":"2007","unstructured":"Agha A, Carpenter R, Bhattacharya S, Edmonson SJ, Carlsen E, Monson JP (2007) Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity. J Endocrinol Invest 30(2):145\u2013149","journal-title":"J Endocrinol Invest"},{"issue":"4","key":"2945_CR2","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.18632\/oncotarget.2964","volume":"6","author":"T Bihani","year":"2015","unstructured":"Bihani T, Ezell SA, Ladd B, Grosskurth SE, Mazzola AM, Pietras M, Reimer C, Zinda M, Fawell S, D\u2019Cruz CM (2015) Resistance to everolimus driven by epigenetic regulation of MYC in ER+breast cancers. Oncotarget 6(4):2407\u20132420","journal-title":"Oncotarget"},{"issue":"1","key":"2945_CR3","doi-asserted-by":"publisher","first-page":"e85155","DOI":"10.1371\/journal.pone.0085155","volume":"9","author":"KM Burchett","year":"2014","unstructured":"Burchett KM, Yan Y, Ouellette MM (2014) Telomerase inhibitor imetelstat (GRN163L) limits the lifespan of human pancreatic cancer cells. PLoS One 9(1):e85155","journal-title":"PLoS One"},{"issue":"15","key":"2945_CR4","doi-asserted-by":"publisher","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","volume":"19","author":"N Burnichon","year":"2010","unstructured":"Burnichon N, Briere JJ, Libe R, Vescovo L, Riviere J, Tissier F, Jouanno E, Jeunemaitre X, Benit P, Tzagoloff A, Rustin P, Bertherat J, Favier J, Gimenez-Roqueplo AP (2010) SDHA is a tumor suppressor gene causing paraganglioma. Hum Mol Genet 19(15):3011\u20133020","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2945_CR5","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1002\/hed.20049","volume":"26","author":"NL Busaidy","year":"2004","unstructured":"Busaidy NL, Jimenez C, Habra MA, Schultz PN, El-Naggar AK, Clayman GL, Asper JA, Diaz EM Jr, Evans DB, Gagel RF, Garden A, Hoff AO, Lee JE, Morrison WH, Rosenthal DI, Sherman SI, Sturgis EM, Waguespack SG, Weber RS, Wirfel K, Vassilopoulou-Sellin R (2004) Parathyroid carcinoma: a 22-year experience. Head Neck 26(8):716\u2013726","journal-title":"Head Neck"},{"issue":"5573","key":"2945_CR6","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1126\/science.296.5573.1655","volume":"296","author":"LC Cantley","year":"2002","unstructured":"Cantley LC (2002) The phosphoinositide 3-kinase pathway. Science 296(5573):1655\u20131657","journal-title":"Science"},{"issue":"12","key":"2945_CR7","doi-asserted-by":"publisher","first-page":"e2562","DOI":"10.1038\/cddis.2016.425","volume":"7","author":"A Celeghin","year":"2016","unstructured":"Celeghin A, Giunco S, Freguja R, Zangrossi M, Nalio S, Dolcetti R, De Rossi A (2016) Short-term inhibition of TERT induces telomere length-independent cell cycle arrest and apoptotic response in EBV-immortalized and transformed B cells. Cell Death Dis 7(12):e2562","journal-title":"Cell Death Dis"},{"issue":"1","key":"2945_CR8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/j.1365-2265.2004.01954.x","volume":"60","author":"F Cetani","year":"2004","unstructured":"Cetani F, Pardi E, Viacava P, Pollina GD, Fanelli G, Picone A, Borsari S, Gazzerro E, Miccoli P, Berti P, Pinchera A, Marcocci C (2004) A reappraisal of the Rb1 gene abnormalities in the diagnosis of parathyroid cancer. Clin Endocrinol (Oxf) 60(1):99\u2013106","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"2945_CR9","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s40618-016-0447-3","volume":"39","author":"F Cetani","year":"2016","unstructured":"Cetani F, Pardi E, Marcocci C (2016) Update on parathyroid carcinoma. J Endocrinol Invest 39(6):595\u2013606","journal-title":"J Endocrinol Invest"},{"key":"2945_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ijsu.2016.05.035","volume":"31","author":"I Christakis","year":"2016","unstructured":"Christakis I, Busaidy NL, Cote GJ, Williams MD, Hyde SM, Silva Figueroa AM, Kwatampora LJ, Clarke CN, Qiu W, Lee JE, Perrier ND (2016) Parathyroid carcinoma and atypical parathyroid neoplasms in MEN1 patients; a clinico-pathologic challenge The MD Anderson case series and review of the literature. Int J Surg 31:10\u201316","journal-title":"Int J Surg"},{"issue":"6","key":"2945_CR11","doi-asserted-by":"publisher","first-page":"e463","DOI":"10.1016\/j.prro.2017.05.009","volume":"7","author":"I Christakis","year":"2017","unstructured":"Christakis I, Silva AM, Williams MD, Garden A, Grubbs EG, Busaidy NL, Lee JE, Perrier ND, Zafereo M (2017) Postoperative local-regional radiation therapy in the treatment of parathyroid carcinoma: the MD Anderson experience of 35\u00a0years. Pract Radiat Oncol 7(6):e463\u2013e470","journal-title":"Pract Radiat Oncol"},{"issue":"6","key":"2945_CR12","first-page":"1320","volume":"78","author":"VL Cryns","year":"1994","unstructured":"Cryns VL, Rubio MP, Thor AD, Louis DN, Arnold A (1994) p53 abnormalities in human parathyroid carcinoma. J Clin Endocrinol Metab 78(6):1320\u20131324","journal-title":"J Clin Endocrinol Metab"},{"key":"2945_CR13","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/B978-0-444-52891-9.00038-5","volume":"111","author":"P Curatolo","year":"2013","unstructured":"Curatolo P, Maria BL (2013) Tuberous sclerosis. Handb Clin Neurol 111:323\u2013331","journal-title":"Handb Clin Neurol"},{"key":"2945_CR14","volume-title":"Pathology and genetics of tumours of endocrine organs","author":"R DeLellis","year":"2004","unstructured":"DeLellis R (2004) Pathology and genetics of tumours of endocrine organs. IARC Press, Lyon, France"},{"issue":"1","key":"2945_CR15","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/ng.3726","volume":"49","author":"A Dunford","year":"2017","unstructured":"Dunford A, Weinstock DM, Savova V, Schumacher SE, Cleary JP, Yoda A, Sullivan TJ, Hess JM, Gimelbrant AA, Beroukhim R, Lawrence MS, Getz G, Lane AA (2017) Tumor-suppressor genes that escape from X-inactivation contribute to cancer sex bias. Nat Genet 49(1):10\u201316","journal-title":"Nat Genet"},{"issue":"6","key":"2945_CR16","doi-asserted-by":"publisher","first-page":"E1103","DOI":"10.1210\/jc.2013-1400","volume":"98","author":"T Dwight","year":"2013","unstructured":"Dwight T, Mann K, Benn DE, Robinson BG, McKelvie P, Gill AJ, Winship I, Clifton-Bligh RJ (2013a) Familial SDHA mutation associated with pituitary adenoma and pheochromocytoma\/paraganglioma. J Clin Endocrinol Metab 98(6):E1103\u2013E1108","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"2945_CR17","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1097\/PAS.0b013e3182671155","volume":"37","author":"T Dwight","year":"2013","unstructured":"Dwight T, Benn DE, Clarkson A, Vilain R, Lipton L, Robinson BG, Clifton-Bligh RJ, Gill AJ (2013b) Loss of SDHA expression identifies SDHA mutations in succinate dehydrogenase-deficient gastrointestinal stromal tumors. Am J Surg Pathol 37(2):226\u2013233","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2945_CR18","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1038\/nrc3802","volume":"14","author":"WD Foulkes","year":"2014","unstructured":"Foulkes WD, Priest JR, Duchaine TF (2014) DICER1: mutations, microRNAs and mechanisms. Nat Rev Cancer 14(10):662\u2013672","journal-title":"Nat Rev Cancer"},{"key":"2945_CR19","unstructured":"FoundationOne. \n                              https:\/\/assets.ctfassets.net\/vhribv12lmne\/6YRrchSINOeSu48YwuesoY\/0c3651c8421fa3647ccede76de9dce61\/MKT-0054-02_F1_TechSpecs_digital.pdf\n                              \n                           . [3\/27\/2018]"},{"issue":"3","key":"2945_CR20","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1530\/EJE-11-0003","volume":"165","author":"K Frank-Raue","year":"2011","unstructured":"Frank-Raue K, Haag C, Schulze E, Keuser R, Raue F, Dralle H, Lorenz K (2011) CDC73-related hereditary hyperparathyroidism: five new mutations and the clinical spectrum. Eur J Endocrinol 165(3):477\u2013483","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2945_CR21","first-page":"787","volume":"13","author":"DC Gotley","year":"1996","unstructured":"Gotley DC, Reeder JA, Fawcett J, Walsh MD, Bates P, Simmons DL, Antalis TM (1996) The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases. Oncogene 13(4):787\u2013795","journal-title":"Oncogene"},{"issue":"1","key":"2945_CR22","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/path.4176","volume":"230","author":"Y Guo","year":"2013","unstructured":"Guo Y, Chekaluk Y, Zhang J, Du J, Gray NS, Wu CL, Kwiatkowski DJ (2013) TSC1 involvement in bladder cancer: diverse effects and therapeutic implications. J Pathol 230(1):17\u201327","journal-title":"J Pathol"},{"issue":"3","key":"2945_CR23","doi-asserted-by":"publisher","first-page":"L9","DOI":"10.1530\/ERC-15-0121","volume":"22","author":"F Haglund","year":"2015","unstructured":"Haglund F, Juhlin CC, Brown T, Ghaderi M, Liu T, Stenman A, Dinets A, Prasad M, Korah R, Xu D, Carling T, Larsson C (2015) TERT promoter mutations are rare in parathyroid tumors. Endocr Relat Cancer 22(3):L9","journal-title":"Endocr Relat Cancer"},{"issue":"5","key":"2945_CR24","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1016\/j.eururo.2012.09.005","volume":"63","author":"AA Hakimi","year":"2013","unstructured":"Hakimi AA, Chen YB, Wren J, Gonen M, Abdel-Wahab O, Heguy A, Liu H, Takeda S, Tickoo SK, Reuter VE, Voss MH, Motzer RJ, Coleman JA, Cheng EH, Russo P, Hsieh JJ (2013) Clinical and pathologic impact of select chromatin-modulating tumor suppressors in clear cell renal cell carcinoma. Eur Urol 63(5):848\u2013854","journal-title":"Eur Urol"},{"issue":"16","key":"2945_CR25","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1038\/sj.onc.1202854","volume":"18","author":"N Hornigold","year":"1999","unstructured":"Hornigold N, Devlin J, Davies AM, Aveyard JS, Habuchi T, Knowles MA (1999) Mutation of the 9q34 gene TSC1 in sporadic bladder cancer. Oncogene 18(16):2657\u20132661","journal-title":"Oncogene"},{"issue":"3","key":"2945_CR26","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.eururo.2016.10.007","volume":"71","author":"JJ Hsieh","year":"2017","unstructured":"Hsieh JJ, Chen D, Wang PI, Marker M, Redzematovic A, Chen YB, Selcuklu SD, Weinhold N, Bouvier N, Huberman KH, Bhanot U, Chevinsky MS, Patel P, Pinciroli P, Won HH, You D, Viale A, Lee W, Hakimi AA, Berger MF, Socci ND, Cheng EH, Knox J, Voss MH, Voi M, Motzer RJ (2017) Genomic biomarkers of a randomized trial comparing first-line everolimus and sunitinib in patients with metastatic renal cell carcinoma. Eur Urol 71(3):405\u2013414","journal-title":"Eur Urol"},{"key":"2945_CR27","unstructured":"https:\/\/www.thermofisher.com\/order\/catalog\/product\/4475346\n                              \n                           . [cited 2018 3\/23]"},{"key":"2945_CR28","unstructured":"https:\/\/www.thermofisher.com\/order\/catalog\/product\/4477685\n                              \n                           . [cited 2018 3\/23]"},{"issue":"2","key":"2945_CR29","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1042\/BJ20080281","volume":"412","author":"J Huang","year":"2008","unstructured":"Huang J, Manning BD (2008) The TSC1\u2013TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 412(2):179\u2013190","journal-title":"Biochem J"},{"issue":"5","key":"2945_CR30","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/1535-7163.MCT-14-0768","volume":"14","author":"H Huynh","year":"2015","unstructured":"Huynh H, Hao HX, Chan SL, Chen D, Ong R, Soo KC, Pochanard P, Yang D, Ruddy D, Liu M, Derti A, Balak MN, Palmer MR, Wang Y, Lee BH, Sellami D, Zhu AX, Schlegel R, Huang A (2015) Loss of tuberous sclerosis complex 2 (TSC2) Is frequent in hepatocellular carcinoma and predicts response to mTORC1 inhibitor everolimus. Mol Cancer Ther 14(5):1224\u20131235","journal-title":"Mol Cancer Ther"},{"issue":"6104","key":"2945_CR31","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1126\/science.1226344","volume":"338","author":"G Iyer","year":"2012","unstructured":"Iyer G, Hanrahan AJ, Milowsky MI, Al-Ahmadie H, Scott SN, Janakiraman M, Pirun M, Sander C, Socci ND, Ostrovnaya I, Viale A, Heguy A, Peng L, Chan TA, Bochner B, Bajorin DF, Berger MF, Taylor BS, Solit DB (2012) Genome sequencing identifies a basis for everolimus sensitivity. Science 338(6104):221","journal-title":"Science"},{"key":"2945_CR32","volume-title":"GeneReviews((R))","author":"MA Jackson","year":"1993","unstructured":"Jackson MA, Rich TA, Hu MI, Perrier ND, Waguespack SG (1993) CDC73-Related Disorders. In: Adam MP et al (eds) GeneReviews((R)). University of Washington, Seattle"},{"key":"2945_CR33","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1186\/s12885-015-1798-4","volume":"15","author":"X Ji","year":"2015","unstructured":"Ji X, Jin S, Qu X, Li K, Wang H, He H, Guo F, Dong L (2015) Lysine-specific demethylase 5C promotes hepatocellular carcinoma cell invasion through inhibition BMP7 expression. BMC Cancer 15:801","journal-title":"BMC Cancer"},{"issue":"15 suppl","key":"2945_CR34","doi-asserted-by":"publisher","first-page":"6088","DOI":"10.1200\/JCO.2017.35.15_suppl.6088","volume":"35","author":"H Kang","year":"2017","unstructured":"Kang H, Schubert AD, Ladenson P, Ball DW, Chung J, Schrock AB, Ross JS, Miller VA, Stephens PJ, Ali SM (2017) Comprehensive genomic profiling of parathyroid carcinoma. J Clin Oncol 35(15 suppl):6088","journal-title":"J Clin Oncol"},{"issue":"3","key":"2945_CR35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1002\/path.4203","volume":"230","author":"K Kasaian","year":"2013","unstructured":"Kasaian K, Wiseman SM, Thiessen N, Mungall KL, Corbett RD, Qian JQ, Nip KM, He A, Tse K, Chuah E, Varhol RJ, Pandoh P, McDonald H, Zeng T, Tam A, Schein J, Birol I, Mungall AJ, Moore RA, Zhao Y, Hirst M, Marra MA, Walker BA, Jones SJ (2013) Complete genomic landscape of a recurring sporadic parathyroid carcinoma. J Pathol 230(3):249\u2013260","journal-title":"J Pathol"},{"issue":"3","key":"2945_CR36","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/nrd4236","volume":"13","author":"KH Khoo","year":"2014","unstructured":"Khoo KH, Verma CS, Lane DP (2014) Drugging the p53 pathway: understanding the route to clinical efficacy. Nat Rev Drug Discov 13(3):217\u2013236","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"2945_CR37","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/35101031","volume":"1","author":"AG Knudson","year":"2001","unstructured":"Knudson AG (2001) Two genetic hits (more or less) to cancer. Nat Rev Cancer 1(2):157\u2013162","journal-title":"Nat Rev Cancer"},{"issue":"15 suppl","key":"2945_CR38","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1200\/jco.2015.33.15_suppl.3608","volume":"33","author":"S Kopetz","year":"2015","unstructured":"Kopetz S, Litzenburger B, Kinyua W, Sajan B, Subbiah V, Zinner R, Wheler JJ, Hong DS, Tsimberidou AM, Overman MJ, Pagliaro LC, Busaidy NL, Westin SN, Glisson BS, Heymach J, Meric-Bernstam F, Shaw KR, Lee JJ, Broaddus R (2015) Prospective evaluation of a 409-gene next generation sequencing platform to facilitate genotype-matched clinical trial enrollment. J Clin Oncol 33(15 suppl):3608","journal-title":"J Clin Oncol"},{"issue":"6","key":"2945_CR39","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1530\/eje.1.02168","volume":"154","author":"AC Lazaris","year":"2006","unstructured":"Lazaris AC, Tseleni-Balafouta S, Papathomas T, Brousalis T, Thomopoulou G, Agrogiannis G, Patsouris ES (2006) Immunohistochemical investigation of angiogenic factors in parathyroid proliferative lesions. Eur J Endocrinol 154(6):827\u2013833","journal-title":"Eur J Endocrinol"},{"issue":"2","key":"2945_CR40","doi-asserted-by":"publisher","first-page":"341","DOI":"10.2147\/tcrm.2007.3.2.341","volume":"3","author":"C Le Tourneau","year":"2007","unstructured":"Le Tourneau C, Raymond E, Faivre S (2007) Sunitinib: a novel tyrosine kinase inhibitor. A brief review of its therapeutic potential in the treatment of renal carcinoma and gastrointestinal stromal tumors (GIST). Ther Clin Risk Manag 3(2):341\u2013348","journal-title":"Ther Clin Risk Manag"},{"issue":"8","key":"2945_CR41","doi-asserted-by":"publisher","first-page":"3106","DOI":"10.1210\/jc.2008-0273","volume":"93","author":"Z Liu","year":"2008","unstructured":"Liu Z, Hou P, Ji M, Guan H, Studeman K, Jensen K, Vasko V, El-Naggar AK, Xing M (2008) Highly prevalent genetic alterations in receptor tyrosine kinases and phosphatidylinositol 3-kinase\/Akt and mitogen-activated protein kinase pathways in anaplastic and follicular thyroid cancers. J Clin Endocrinol Metab 93(8):3106\u20133116","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"2945_CR42","doi-asserted-by":"publisher","first-page":"5459","DOI":"10.1158\/1078-0432.CCR-07-5270","volume":"14","author":"J Matsui","year":"2008","unstructured":"Matsui J, Funahashi Y, Uenaka T, Watanabe T, Tsuruoka A, Asada M (2008) Multi-kinase inhibitor E7080 suppresses lymph node and lung metastases of human mammary breast tumor MDA-MB-231 via inhibition of vascular endothelial growth factor-receptor (VEGF-R) 2 and VEGF-R3 kinase. Clin Cancer Res 14(17):5459\u20135465","journal-title":"Clin Cancer Res"},{"issue":"18","key":"2945_CR43","doi-asserted-by":"publisher","first-page":"16663","DOI":"10.18632\/oncotarget.4389","volume":"6","author":"MA Mosrati","year":"2015","unstructured":"Mosrati MA, Malmstrom A, Lysiak M, Krysztofiak A, Hallbeck M, Milos P, Hallbeck AL, Bratthall C, Strandeus M, Stenmark-Askmalm M, Soderkvist P (2015) TERT promoter mutations and polymorphisms as prognostic factors in primary glioblastoma. Oncotarget 6(18):16663\u201316673","journal-title":"Oncotarget"},{"key":"2945_CR59","unstructured":"NEXAVAR Prescribing Information (2018) Bayer HealthCare Pharmaceuticals, Inc; Whippany, NJ"},{"key":"2945_CR44","doi-asserted-by":"publisher","first-page":"e395","DOI":"10.1200\/EdBook_AM.2013.33.e395","volume":"33","author":"TK Owonikoko","year":"2013","unstructured":"Owonikoko TK, Khuri FR (2013) Targeting the PI3\u00a0K\/AKT\/mTOR pathway: biomarkers of success and tribulation. Am Soc Clin Oncol Educ Book 33:e395","journal-title":"Am Soc Clin Oncol Educ Book"},{"issue":"6","key":"2945_CR45","doi-asserted-by":"publisher","first-page":"e92061","DOI":"10.1172\/jci.insight.92061","volume":"2","author":"C Pandya","year":"2017","unstructured":"Pandya C, Uzilov AV, Bellizzi J, Lau CY, Moe AS, Strahl M, Hamou W, Newman LC, Fink MY, Antipin Y, Yu W, Stevenson M, Cavaco BM, Teh BT, Thakker RV, Morreau H, Schadt EE, Sebra R, Li SD, Arnold A, Chen R (2017) Genomic profiling reveals mutational landscape in parathyroid carcinomas. JCI Insight 2(6):e92061","journal-title":"JCI Insight"},{"issue":"2","key":"2945_CR46","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.critrevonc.2012.11.008","volume":"86","author":"E Paolicchi","year":"2013","unstructured":"Paolicchi E, Crea F, Farrar WL, Green JE, Danesi R (2013) Histone lysine demethylases in breast cancer. Crit Rev Oncol Hematol 86(2):97\u2013103","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"2945_CR47","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/ng.2947","volume":"46","author":"CD Robles-Espinoza","year":"2014","unstructured":"Robles-Espinoza CD, Harland M, Ramsay AJ, Aoude LG, Quesada V, Ding Z, Pooley KA, Pritchard AL, Tiffen JC, Petljak M, Palmer JM, Symmons J, Johansson P, Stark MS, Gartside MG, Snowden H, Montgomery GW, Martin NG, Liu JZ, Choi J, Makowski M, Brown KM, Dunning AM, Keane TM, Lopez-Otin C, Gruis NA, Hayward NK, Bishop DT, Newton-Bishop JA, Adams DJ (2014) POT1 loss-of-function variants predispose to familial melanoma. Nat Genet 46(5):478\u2013481","journal-title":"Nat Genet"},{"issue":"5","key":"2945_CR48","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1086\/340450","volume":"70","author":"A Rokman","year":"2002","unstructured":"Rokman A, Ikonen T, Seppala EH, Nupponen N, Autio V, Mononen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70(5):1299\u20131304","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2945_CR49","doi-asserted-by":"publisher","first-page":"2773","DOI":"10.1073\/pnas.050400997","volume":"97","author":"C Schaffner","year":"2000","unstructured":"Schaffner C, Idler I, Stilgenbauer S, Dohner H, Lichter P (2000) Mantle cell lymphoma is characterized by inactivation of the ATM gene. Proc Natl Acad Sci USA 97(6):2773\u20132778","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"2945_CR50","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1038\/nrendo.2012.102","volume":"8","author":"KM Schulte","year":"2012","unstructured":"Schulte KM, Talat N (2012) Diagnosis and management of parathyroid cancer. Nat Rev Endocrinol 8(10):612\u2013622","journal-title":"Nat Rev Endocrinol"},{"issue":"18","key":"2945_CR51","doi-asserted-by":"publisher","first-page":"1722","DOI":"10.1056\/NEJMoa031237","volume":"349","author":"TM Shattuck","year":"2003","unstructured":"Shattuck TM, Valimaki S, Obara T, Gaz RD, Clark OH, Shoback D, Wierman ME, Tojo K, Robbins CM, Carpten JD, Farnebo LO, Larsson C, Arnold A (2003) Somatic and germ-line mutations of the HRPT2 gene in sporadic parathyroid carcinoma. N Engl J Med 349(18):1722\u20131729","journal-title":"N Engl J Med"},{"issue":"1","key":"2945_CR52","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/5042","volume":"21","author":"L Shayesteh","year":"1999","unstructured":"Shayesteh L, Lu Y, Kuo WL, Baldocchi R, Godfrey T, Collins C, Pinkel D, Powell B, Mills GB, Gray JW (1999) PIK3CA is implicated as an oncogene in ovarian cancer. Nat Genet 21(1):99\u2013102","journal-title":"Nat Genet"},{"issue":"5","key":"2945_CR53","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jmoldx.2013.05.003","volume":"15","author":"RR Singh","year":"2013","unstructured":"Singh RR, Patel KP, Routbort MJ, Reddy NG, Barkoh BA, Handal B, Kanagal-Shamanna R, Greaves WO, Medeiros LJ, Aldape KD, Luthra R (2013) Clinical validation of a next-generation sequencing screen for mutational hotspots in 46 cancer-related genes. J Mol Diagn 15(5):607\u2013622","journal-title":"J Mol Diagn"},{"issue":"10","key":"2945_CR54","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/bjc.2014.518","volume":"111","author":"RR Singh","year":"2014","unstructured":"Singh RR, Patel KP, Routbort MJ, Aldape K, Lu X, Manekia J, Abraham R, Reddy NG, Barkoh BA, Veliyathu J, Medeiros LJ, Luthra R (2014) Clinical massively parallel next-generation sequencing analysis of 409 cancer-related genes for mutations and copy number variations in solid tumours. Br J Cancer 111(10):2014\u20132023","journal-title":"Br J Cancer"},{"issue":"4","key":"2945_CR55","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1038\/nrc.2016.15","volume":"16","author":"G Stracquadanio","year":"2016","unstructured":"Stracquadanio G, Wang X, Wallace MD, Grawenda AM, Zhang P, Hewitt J, Zeron-Medina J, Castro-Giner F, Tomlinson IP, Goding CR, Cygan KJ, Fairbrother WG, Thomas LF, Saetrom P, Gemignani F, Landi S, Schuster-Bockler B, Bell DA, Bond GL (2016) The importance of p53 pathway genetics in inherited and somatic cancer genomes. Nat Rev Cancer 16(4):251\u2013265","journal-title":"Nat Rev Cancer"},{"key":"2945_CR56","doi-asserted-by":"publisher","first-page":"2185","DOI":"10.1038\/ncomms3185","volume":"4","author":"J Vinagre","year":"2013","unstructured":"Vinagre J, Almeida A, Populo H, Batista R, Lyra J, Pinto V, Coelho R, Celestino R, Prazeres H, Lima L, Melo M, da Rocha AG, Preto A, Castro P, Castro L, Pardal F, Lopes JM, Santos LL, Reis RM, Cameselle-Teijeiro J, Sobrinho-Simoes M, Lima J, Maximo V, Soares P (2013) Frequency of TERT promoter mutations in human cancers. Nat Commun 4:2185","journal-title":"Nat Commun"},{"issue":"1","key":"2945_CR57","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1093\/hmg\/3.1.153","volume":"3","author":"J Wu","year":"1994","unstructured":"Wu J, Ellison J, Salido E, Yen P, Mohandas T, Shapiro LJ (1994) Isolation and characterization of XE169, a novel human gene that escapes X-inactivation. Hum Mol Genet 3(1):153\u2013160","journal-title":"Hum Mol Genet"},{"issue":"25","key":"2945_CR58","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1200\/JCO.2014.55.5094","volume":"32","author":"M Xing","year":"2014","unstructured":"Xing M, Liu R, Liu X, Murugan AK, Zhu G, Zeiger MA, Pai S, Bishop J (2014) BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence. J Clin Oncol 32(25):2718\u20132726","journal-title":"J Clin Oncol"},{"issue":"2","key":"2945_CR60","doi-asserted-by":"publisher","first-page":"E360","DOI":"10.1210\/jc.2014-3238","volume":"100","author":"W Yu","year":"2015","unstructured":"Yu W, McPherson JR, Stevenson M, van Eijk R, Heng HL, Newey P, Gan A, Ruano D, Huang D, Poon SL, Ong CK, van Wezel T, Cavaco B, Rozen SG, Tan P, Teh BT, Thakker RV, Morreau H (2015) Whole-exome sequencing studies of parathyroid carcinomas reveal novel PRUNE2 mutations, distinctive mutational spectra related to APOBEC-catalyzed DNA mutagenesis and mutational enrichment in kinases associated with cell migration and invasion. J Clin Endocrinol Metab 100(2):E360\u2013E364","journal-title":"J Clin Endocrinol Metab"},{"issue":"41","key":"2945_CR61","doi-asserted-by":"publisher","first-page":"5497","DOI":"10.1038\/onc.2008.245","volume":"27","author":"TL Yuan","year":"2008","unstructured":"Yuan TL, Cantley LC (2008) PI3\u00a0K pathway alterations in cancer: variations on a theme. Oncogene 27(41):5497\u20135510","journal-title":"Oncogene"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-019-02945-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-019-02945-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,13]],"date-time":"2020-07-13T19:10:25Z","timestamp":1594667425000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-019-02945-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,15]]},"references-count":61,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["2945"],"URL":"https:\/\/doi.org\/10.1007\/s00432-019-02945-9","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,15]]},"assertion":[{"value":"27 February 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"NLB has received grant funding from Novartis and Bayer and consulting fees from Eisai. MEC has received grant funding from Eisai. MK, HTN, LK, CC, AS, EI, SGW, CJ, MH, SS, SK, RB, RD, KW, MW, MZ, NP: nothing to disclose","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}